Integrated Annual Report 2024

8 GoodwilI and intangible assets

Accounting policy

Goodwill

Goodwill represents the excess of the cost of an acquisition over dsm-firmenich’s share in the net fair value of the identifiable assets and liabilities in a business combination. Goodwill paid on acquisition of a business is included in intangible assets. Goodwill paid on acquisition of joint ventures or associates is included in the carrying amount of these entities. Goodwill recognized as an intangible asset is tested for impairment annually, and when there are indications that the carrying amount may exceed the recoverable amount. A gain or loss on the disposal of an operation includes the goodwill allocated to the operation sold.

Intangible assets acquired as part of a business combination

Intangible assets acquired in a business combination are recognized at fair value on the date of acquisition and subsequently amortized on a straight-line basis over their expected useful lives. The expected useful lives vary from four to 20 years.

Separately acquired intangible assets

Separately acquired licenses, patents, application software and other purchased rights are carried at historical cost less straight-line amortization and less any impairment losses. The expected useful lives vary from four to 20 years.

Capital expenditure that is directly related to the development of application software is recognized as an intangible asset and amortized over its estimated useful life (five to eight years). Costs of software maintenance are expensed when incurred.

Internally generated intangible assets

Research costs are expensed when incurred. Development expenditure is capitalized if the recognition criteria are met and if it is demonstrated that it is technically feasible to complete the asset; that the entity intends to complete the asset; that the entity is able to sell the asset; that the asset is capable of generating future economic benefits; that adequate resources are available to complete the asset; and that the expenditure attributable to the asset can be reliably measured. Development expenditure that meets the recognition criteria is amortized over the asset’s useful life on a straight-line basis. As long as internally generated intangible assets are under construction, they are not amortized as they are not yet available for use. Instead, they are subject to a review for impairment annually, or more frequently if events or circumstances indicate this is necessary. Any impairment is charged to the income statement as it arises.

Impairment of non-financial assets

When there are indications that the carrying amount of a non-financial asset (goodwill, an intangible asset, or an item of property, plant and equipment) may exceed the estimated recoverable amount (the higher of its value in use and fair value less costs of disposal), the possible existence of an impairment loss is investigated. If an asset does not generate largely independent cash flows, the recoverable amount is determined for the cash generating unit (CGU) to which the asset belongs. In assessing the value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market interest rates and the risks specific to the asset or CGU. When the recoverable amount of a non-financial asset or a CGU is less than its carrying amount, the carrying amount is impaired to its recoverable amount and an impairment charge is recognized in profit or loss. An impairment loss is reversed when there has been a change in estimate that is relevant for the determination of the asset’s recoverable amount since the last impairment loss was recognized. Impairment losses for goodwill are never reversed.

Estimates and judgments

Key estimates and judgments dsm-firmenich makes in the accounting for goodwill and intangible assets relate to:

  • The amortization period of intangible assets, which depends on their useful lives
  • The determination of CGUs, which depends on the capacity of the asset or group of assets to generate independent cash flows
  • The estimation and allocation of future cash flows, growth rates, discount rates and fair values minus costs of disposal for the impairment testing of goodwill and intangible assets. These estimates are based on historical and current market rates, quoted prices, experience, current business outlooks, and are validated by external valuation specialists, where deemed necessary by management
Intangible assets

 

 

Goodwill

 

Customer base

 

Brands and trade­marks

 

Techno­logy and formulas

 

Software, licenses and patents

 

Internally generated

 

Other

 

Total

Balance at 1 January 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost

 

2,989

 

1,249

 

124

 

1,005

 

612

 

576

 

270

 

6,825

Amortization and impairment losses

 

5

 

596

 

62

 

270

 

363

 

186

 

196

 

1,678

Carrying amount

 

2,984

 

653

 

62

 

735

 

249

 

390

 

74

 

5,147

Changes in carrying amount:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- Capital expenditure

 

 

1

 

 

 

2

 

124

 

2

 

129

- Put into operation

 

 

2

 

2

 

1

 

57

 

(62)

 

 

- Acquisitions

 

8,398

 

3,451

 

658

 

1,149

 

71

 

52

 

10

 

13,789

- Disposal subs

 

 

 

 

 

(1)

 

 

 

(1)

- Amortization

 

 

(178)

 

(40)

 

(118)

 

(83)

 

(38)

 

(20)

 

(477)

- Impairment losses

 

(28)

 

(3)

 

(3)

 

(13)

 

(6)

 

(13)

 

(4)

 

(70)

- Exchange differences

 

(61)

 

174

 

30

 

53

 

8

 

13

 

(5)

 

212

- Reclassification to held for sale

 

 

 

 

 

 

2

 

 

2

- Transfers

 

 

 

22

 

(34)

 

40

 

(29)

 

6

 

5

- Other

 

 

3

 

1

 

 

24

 

 

(26)

 

2

 

 

8,309

 

3,450

 

670

 

1,038

 

112

 

49

 

(37)

 

13,591

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost

 

11,315

 

4,880

 

837

 

2,174

 

813

 

676

 

258

 

20,953

Amortization and impairment losses

 

22

 

777

 

105

 

401

 

452

 

237

 

221

 

2,215

Carrying amount

 

11,293

 

4,103

 

732

 

1,773

 

361

 

439

 

37

 

18,738

- Of which acquisition-related

 

11,293

 

4,103

 

732

 

1,773

 

76

 

 

11

 

17,988

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Changes in carrying amount:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- Capital expenditure

 

 

 

 

 

1

 

113

 

3

 

117

- Put into operation

 

 

(1)

 

4

 

11

 

53

 

(70)

 

3

 

- Disposals and deconsolidations

 

(47)

 

(1)

 

 

 

 

(11)

 

(1)

 

(60)

- Amortization

 

 

(250)

 

(69)

 

(146)

 

(108)

 

(25)

 

(11)

 

(609)

- Impairment losses

 

(50)

 

(1)

 

(4)

 

(55)

 

(1)

 

(5)

 

 

(116)

- Exchange differences

 

51

 

(32)

 

(3)

 

(4)

 

(1)

 

(5)

 

1

 

7

- Transfers

 

 

(15)

 

(16)

 

31

 

10

 

(33)

 

24

 

1

 

 

(46)

 

(300)

 

(88)

 

(163)

 

(46)

 

(36)

 

19

 

(660)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at 31 December 2024

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost

 

11,302

 

4,682

 

858

 

2,068

 

1,013

 

632

 

231

 

20,786

Amortization and impairment losses

 

55

 

879

 

214

 

458

 

698

 

229

 

175

 

2,708

Carrying amount

 

11,247

 

3,803

 

644

 

1,610

 

315

 

403

 

56

 

18,078

- Of which acquisition-related

 

11,247

 

3,803

 

644

 

1,610

 

66

 

 

17

 

17,387

The amortization and impairment losses of goodwill and intangible assets are included in Cost of sales, Marketing & Sales, Research & Development, and General & Administrative expenses.

Where dsm-firmenich acquired entities in business combinations in the past, they were accounted for by the acquisition method, resulting in recognition of mainly goodwill, customer- and marketing-related, and technology-based intangible assets.

The main intangible assets recognized as a result of the merger in 2023 are customer relationships for €3,407 million, technology for €1,044 million, and trademarks for €648 million. Furthermore, an amount of €8,251 million was recognized as goodwill.

Other significant intangibles were mainly obtained during the acquisitions of Erber Group and Glycom in 2020, and F&F Amyris and First Choice Ingredients in 2021. Intangible assets are amortized on a straight-line basis and subject to impairment trigger testing.

There are no intangible assets with an indefinite useful life (same as in 2023). The carrying amount of the internally generated intangible assets includes €137 million (2023: €133 million) that relates mainly to strategic projects which are not being amortized yet. The recoverable amount of these projects was estimated based on the present value of the future cash flows expected to be derived from the projects (value-in-use).

Goodwill

The annual impairment tests of goodwill are performed in the fourth quarter. The recoverable amount of the CGUs is based on a value-in-use calculation. More specifically, the cash flow projections are based on the budget for 2025, as approved by management, which is extrapolated throughout the remainder of the forecast period using management’s internal forecasts. The key assumptions in the cash flow projections relate to the market growth for the CGUs and the related revenue projections, EBITDA developments, and the rates used for discounting cash flows.

The CGUs dsm-firmenich identified in 2024 are Perfumery & Beauty (P&B), Taste, Texture & Health (TTH), Health, Nutrition & Care (HNC), and Animal Nutrition & Health (ANH).

Goodwill per Cash generating unit

 

 

2024

 

2023

Perfumery & Beauty (P&B)

 

4,169

 

4,191

Taste, Texture & Health (TTH)

 

3,718

 

3,739

Health, Nutrition & Care (HNC)

 

1,782

 

1,784

Animal Nutrition & Health (ANH)

 

1,578

 

1,579

Total

 

11,247

 

11,293

For ANH and HNC, the growth assumptions are based on the growth of the global food and feed markets, and the vitamin transformation program; for TTH on the growth assumptions of the global food and beverage markets; and for P&B on the growth assumptions of the global fragrances and personal care markets.

Key assumptions for goodwill impairment tests

 

 

2024

 

2023

Forecast period (years)

 

 

 

 

- Mature business

 

5

 

5

- Emerging business

 

10

 

10

 

 

 

 

 

Terminal value growth

 

2.0%

 

2.0%

 

 

 

 

 

Pre-tax discount rate

 

 

 

 

P&B

 

9.0%

 

8.7%

TTH

 

8.7%

 

8.6%

HNC

 

8.6%

 

7.9%

ANH

 

9.6%

 

9.2%

 

 

 

 

 

Organic sales growth (year 1–5)

 

 

 

 

P&B

 

2%–4%

 

1%–4%

TTH

 

1%–6%

 

3%–8%

HNC

 

0%–7%

 

6%–8%

ANH

 

4%–13%

 

4%–8%

Based on the sensitivity tests performed on the impairment test of the CGUs P&B and TTH, it was identified that a reasonably possible adverse change in the pre-tax discount rate could cause the carrying amount of these CGUs to exceed their recoverable amount. Holding all other factors constant, increases of, respectively, 182 basis points and 175 basis points in the pre-tax discount rates of P&B and TTH would result in recoverable amounts equal to the carrying amounts of these CGUs. The headroom of P&B and TTH amounted to €2,553 million and €2,130 million, respectively. The remainder of the sensitivity tests performed indicates that the conclusions of the impairment test of the CGUs would not have been different if a reasonably adverse change in any other key parameter had been assumed.

Topic filter

Results